Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-12-05 4:45 pm Purchase | 13G | KURA ONCOLOGY INC KURA | BIOTECHNOLOGY VALUE FUND L P | 3,547,083 5.3% | 2,301,171 (+184.70%) | View |
| 2022-11-10 4:51 pm Unchanged | 13D | Rain Oncology Inc. RAIN | BIOTECHNOLOGY VALUE FUND L P | 3,526,729 14.2% | 0 (Unchanged) | View |
| 2022-11-07 4:50 pm Purchase | 13G | Aravive Inc. ARAV | BIOTECHNOLOGY VALUE FUND L P | 6,109,058 9.99% | 6,109,058 (New Position) | View |
| 2022-09-29 4:28 pm Purchase | 13G | ALLAKOS INC ALLK | BIOTECHNOLOGY VALUE FUND L P | 5,006,921 5.9% | 5,006,921 (New Position) | View |
| 2022-09-26 4:57 pm Purchase | 13G | Third Harmonic Bio Inc. THRD | BIOTECHNOLOGY VALUE FUND L P | 3,501,814 9.1% | 3,501,814 (New Position) | View |
| 2022-09-26 4:54 pm Purchase | 13G | POINT Biopharma Global Inc. PNT | BIOTECHNOLOGY VALUE FUND L P | 5,590,048 5.4% | 2,669,522 (+91.41%) | View |
| 2022-08-26 5:11 pm Purchase | 13G | Vigil Neuroscience Inc. VIGL | BIOTECHNOLOGY VALUE FUND L P | 2,739,727 7.5% | 2,739,727 (New Position) | View |
| 2022-08-23 4:45 pm Purchase | 13D | KYMERA THERAPEUTICS INC KYMR | BIOTECHNOLOGY VALUE FUND L P | 4,692,604 8.6% | 553,846 (+13.38%) | View |
| 2022-08-11 4:48 pm Purchase | 13D | CTI BIOPHARMA CORP CTIC | BIOTECHNOLOGY VALUE FUND L P | 28,463,021 19.99% | 11,339,998 (+66.23%) | View |
| 2022-07-29 4:37 pm Purchase | 13G | CytomX Therapeutics Inc. CTMX | BIOTECHNOLOGY VALUE FUND L P | 6,595,801 10.1% | 792,101 (+13.65%) | View |
| 2022-07-19 5:13 pm Sale | 13G | CONTRAFECT Corp CFRX | BIOTECHNOLOGY VALUE FUND L P | 1,847,299 4.5% | -2,125,001 (-53.50%) | View |
| 2022-07-12 4:40 pm Purchase | 13G | ESSA Pharma Inc. EPIX | BIOTECHNOLOGY VALUE FUND L P | 8,748,629 19.9% | 4,183,387 (+91.64%) | View |
| 2022-07-11 5:03 pm Purchase | 13G | 89bio Inc. ETNB | BIOTECHNOLOGY VALUE FUND L P | 3,898,000 9.99% | 3,898,000 (New Position) | View |
| 2022-06-21 4:53 pm Purchase | 13G | 4D Molecular Therapeutics Inc. FDMT | BIOTECHNOLOGY VALUE FUND L P | 4,007,413 12.4% | 2,001,551 (+99.79%) | View |
| 2022-06-16 5:24 pm Purchase | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | BIOTECHNOLOGY VALUE FUND L P | 6,894,345 7.3% | 6,894,345 (New Position) | View |
| 2022-06-06 5:25 pm Purchase | 13G | REPARE THERAPEUTICS INC RPTX | BIOTECHNOLOGY VALUE FUND L P | 8,141,988 19.4% | 3,283,227 (+67.57%) | View |
| 2022-06-01 5:00 pm Purchase | 13D | KYMERA THERAPEUTICS INC KYMR | BIOTECHNOLOGY VALUE FUND L P | 4,138,758 8% | 552,100 (+15.39%) | View |
| 2022-05-26 5:09 pm Purchase | 13G | Annexon Inc. ANNX | BIOTECHNOLOGY VALUE FUND L P | 3,343,194 8.7% | 3,343,194 (New Position) | View |
| 2022-05-02 5:02 pm Purchase | 13G | iTeos Therapeutics Inc. ITOS | BIOTECHNOLOGY VALUE FUND L P | 1,929,201 5.4% | 1,929,201 (New Position) | View |
| 2022-05-02 4:59 pm Purchase | 13G | IDEAYA Biosciences Inc. IDYA | BIOTECHNOLOGY VALUE FUND L P | 1,964,859 5.1% | 1,964,300 (+351395.35%) | View |